Mechanistically, Plg-RKT may regulate breast cancer progression by binding plasminogen on cancer cell surfaces to promote its activation to plasmin, leading to fibrinolysis, extracellular matrix degradation and activation of proenzymes of MMPs. This evidence concerns the gene PLG and breast cancer.